Activation of complement by 405-nm light in serum from porphyria cutanea tarda

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of Dermatological Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00404312PMID 4015182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of complement in the skin after PUVA therapy.

  1984cited by this paper
• Activation of the alternative complement pathway by 405 nm light in serum from porphyric rat.

  1984cited by this paper
• Role of complement and polymorphonuclear cells in demethylchlortetracycline-induced phototoxicity in guinea pigs. Inhibition by decomplementation in vivo.

  1983cited by this paper
• [Complement hemolytic activity (CH50), C3 and C4 levels in serum and plasma of the patients with various liver diseases (author's transl)].

  1981cited by this paper
• Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm light.

  1981cited by this paper
• Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda.

  1981cited by this paper
• Role of complement in porphyrin-induced photosensitivity.

  1981influential reference
• Interaction of porphyrins with proteins.

  1977cited by this paper
• Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

  1976cited by this paper
• The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.

  1974cited by this paper
• Plasma porphyrin concentrations in porphyria cutanea tarda.

  1973cited by this paper

• The Role of Complement in UVB-lnduced Inflammation

  2021cites this paper
• Direct immunofluorescence testing in the diagnosis of immunobullous disease, collagen vascular disease, and vascular injury syndromes.

  2012cites this paper
• Approaches to Treatment and Prevention of Human Porphyrias

  2012cites this paper
• Genetic, biocheminal, and biophysical studies of the heme biosynthetic pathway.

  2011cites this paper
• Estudo da imunofluorescência direta, imunomapeamento e microscopia ótica na porfiria cutânea tardia Study of direct immunofluorescence, immunofluorescence mapping and light microscopy in porphyria cutanea tarda

  2010cites this paper
• Study of direct immunofluorescence, immunofluorescence mapping and light microscopy in porphyria cutanea tarda.

  2010cites this paper
• The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.

  2008cites this paper
• Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda.

  2007cites this paper
• Porfiria cutânea tardia

  2006cites this paper
• The porphyrias

  2001cites this paper
• Mechanisms of photosensitivity in porphyric patients with special emphasis on erythropoietic protoporphyria.

  1991cites this paper
• Role of complement in chlorpromazine-induced phototoxicity.

  1986cites this paper
• The role of complement in UVB-induced inflammation.

  1986cites this paper